Category:
Active Pharmaceutical Ingredients
CAS NO:
1
Standard:
USP;BP,
Dasatinib, Erlotinib, and Imatinib Mesylate are tyrosine kinase inhibitors (TKIs) used in oncology. Key specifications include Dasatinib (C21H26N7NaO5S, CAS 302961-53-7), Erlotinib (C22H23ClN4O3, CAS 183321-74-6), and Imatinib Mesylate (C29H31N7O·CH4O3S, CAS 152473-11-5). Production relies on high-purity synthesis with rigorous HPLC control.
Strictly store below 25°C in dry, dark conditions. Handle with PPE to avoid inhalation or skin contact. Clinical use requires monitoring for hematological toxicity and fluid retention risks.